Meta-analysis of epidemiologic studies on cigarette smoking and liver cancer

International Journal of Epidemiology

Volumn 38, Issue 6, 2009, Pages 1497-1511

  Lee, Yuan Chin Amy ^a   Cohet, Catherine ^a   Yang, Yu Ching ^a,b   Stayner, Leslie ^c   Hashibe, Mia ^a   Straif, Kurt ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Cigarette smoking; Liver cancer; Meta analysis

Indexed keywords

CANCER; CONFIDENCE INTERVAL; DOSE-RESPONSE RELATIONSHIP; EPIDEMIOLOGY; HETEROGENEITY; META-ANALYSIS; SMOKING; TOBACCO;

ALCOHOL CONSUMPTION; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CHINA; CIGARETTE SMOKING; COHORT ANALYSIS; EPIDEMIOLOGICAL DATA; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CANCER; LIVER CARCINOGENESIS; PRIORITY JOURNAL; PUBLIC HEALTH; PUBLICATION; ASIA; EUROPE; FEMALE; LIVER TUMOR; MALE; META ANALYSIS; PREVALENCE; REVIEW; RISK; RISK FACTOR; SMOKING; UNITED STATES;

NICOTIANA TABACUM;

ASIA; CASE-CONTROL STUDIES; COHORT STUDIES; EUROPE; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; ODDS RATIO; PREVALENCE; PUBLIC HEALTH; RISK FACTORS; SMOKING; UNITED STATES;

EID: 75349105369     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyp280     Document Type: Article

References (117)

1. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide, Version 2.0. IARC CancerBase No. 5. Lyon, France: IARC Press, 2004.
2. IARC Working Group. Hepatitis viruses. IARC Monogr Eval Carcinogen Risks Humans 1994;59:1-286.
3. IARC Working Group. Some traditional herbal medicines, some mycotoxins, naphthalene and styrene. IARC Monogr Eval Carcinogen Risks Humans 2002;82:1-590.
4. IARC Working Group. Alcoholic beverage consumption and ethyl carbamate (urethane). IARC Monogr Eval Carcinogen Risks Humans 2008 (in press).
5. IARC Working Group. Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy. IARC Monogr Eval Carcinogen Risks Humans 2007;91:1-528.
6. IARC Working Group. 1,3-Butadiene, ethylene oxide and vinyl halides (vinyl fluoride, vinyl chloride and vinyl bromide). IARC Monogr Eval Carcinogen Risks Humans 2008;97:1-510.
7. IARC Working Group. Some internally deposited radionuclides. IARC Monogr Eval Carcinogen Risks Humans 2001;78:1-596.
8. Goldacre MJ, Wotton CJ, Yeates D, Seagroatt V, Collier J. Liver cirrhosis, other liver diseases, pancreatitis and subsequent cancer: record linkage study. Eur J Gastroenterol Hepatol 2008;20:384-92.
9. Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 2004;127 (5 Suppl 1):S35-50.
10. IARC Working Group. Schistosomes, liver flukes and Helicobacter pylori. IARC Monogr Eval Carcinogen Risks Humans 1994;61:1-280.
11. IARC Working Group. Some N-Nitroso compounds. IARC Monogr Eval Carcinogen Risks Humans 1978;17:1-365.
12. IARC Working Group. Overall evaluations of carcinogenicity: an updating of IARC monographs volumes 1 to 42. IARC Monogr Eval Carcinogen Risks Humans 1987;S7:1-440.
13. Dooley KL, Von Tungeln LS, Bucci T, Fu PP, Kadlubar FF. Comparative carcinogenicity of 4-aminobiphenyl and the food pyrolysates, Glu-P-1, IQ, PhIP, and MeIQx in the neonatal B6C3F1 male mouse. Cancer Lett 1992;62: 205-9.
14. Wang LY, Chen CJ, Zhang YJ et al. 4-Aminobiphenyl DNA damage in liver tissue of hepatocellular carcinoma patients and controls. Am J Epidemiol 1998;147:315-23.
15. IARC Working Group. Some drinking-water disinfectants and contaminants, including arsenic. IARC Monogr Eval Carcinogen Risks Humans 2004;84:1-512.
16. Grosse Y, Baan R, Straif K et al. Carcinogenicity of 1,3-butadiene, ethylene oxide, vinyl chloride, vinyl fluoride, and vinyl bromide. Lancet Oncol 2007;8:679-80.
17. Hammond EC. Smoking in relation to the death rates of one million men and women. Natl Cancer Inst Monogr 1966;19:127-204.
18. Basa GF, Hirayama T, Cruz-Basa AG. Cancer epidemiology in the Philippines. Natl Cancer Inst Monogr 1977;47: 45-56.
19. Hirayama T. A large-scale cohort study on risk factors for primary liver cancer, with special reference to the role of cigarette smoking. Cancer Chemother Pharmacol 1989;23: S114-17.
20. Tu JT, Gao RN, Zhang DH, Gu BC. Hepatitis B virus and primary liver cancer on Chongming Island, People's Republic of China. Natl Cancer Inst Monogr 1985;69:213-15.
21. IARC Working Group. Tobacco smoking. IARC Monogr Eval Carcinogen Risks Humans 1986;38:1-421.
22. IARC Working Group. Tobacco smoke and involuntary smoking. IARC Monogr Eval Carcinogen Risks Humans 2004;83:1-1438.
23. Department of Health and Human Services CfDCaPNCfCDPaHPOoSaH. The health consequences of smoking: a report of the Surgeon General. GA: Atlanta, 2004.
24. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
25. Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 1992;135: 1301-9.
26. Chen SY, Wang LY, Lunn RM et al. Polycyclic aromatic hydrocarbon-DNA adducts in liver tissues of hepatocellular carcinoma patients and controls. Int J Cancer 2002;99:14-21.
27. Lund E, Zeiner-Henriksen T. Smoking as a risk factor for different cancer forms among 26,000 Norwegian men and women. A comparison of a material of smokers from the Norwegian Cancer Registry. Tidsskr Nor Laegeforen 1981; 101:1937-40.
28. Carstensen JM, Pershagen G, Eklund G. Mortality in relation to cigarette and pipe smoking: 16 years' observation of 25,000 Swedish men. J Epidemiol Community Health 1987;41:166-72.
29. Nordlund LA, Carstensen JM, Pershagen G. Cancer incidence in female smokers: a 26-year follow-up. Int J Cancer 1997;73:625-28.
30. McLaughlin JK, Hrubec Z, Blot WJ, Fraumeni JF Jr. Smoking and cancer mortality among U.S. veterans: a 26-year follow-up. Int J Cancer 1995;60:190-93.
31. Oshima A, Tsukuma H, Hiyama T, Fujimoto I, Yamano H, Tanaka M. Follow-up study of HBs Ag-positive blood donors with special reference to effect of drinking and smoking on development of liver cancer. Int J Cancer 1984;34:775-79.
32. Kono S, Ikeda M, Tokudome S, Nishizumi M, Kuratsune M. Cigarette smoking, alcohol and cancer mortality: a cohort study of male Japanese physicians. Jpn J Cancer Res 1987;78:1323-28.
33. Akiba S, Hirayama T. Cigarette smoking and cancer mortality risk in Japanese men and women-results from reanalysis of the six-prefecture cohort study data. Environ Health Perspect 1990;87:19-26.
34. Shibata A, Fukuda K, Toshima H, Tashiro H, Hirohata T. The role of cigarette smoking and drinking in the development of liver cancer: 28 years of observations on male cohort members in a farming and fishing area. Cancer Detect Prev 1990;14:617-23.
35. Kato I, Tominaga S, Ikari A. The risk and predictive factors for developing liver cancer among patients with decompensated liver cirrhosis. Jpn J Clin Oncol 1992;22: 278-85.
36. Tsukuma H, Hiyama T, Tanaka S et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993;328:1797-801.
37. Goodman MT, Moriwaki H, Vaeth M, Akiba S, Hayabuchi H, Mabuchi K. Prospective cohort study of risk factors for primary liver cancer in Hiroshima and Nagasaki, Japan. Epidemiology 1995;6:36-41.
38. Chiba T, Matsuzaki Y, Abei M et al. The role of previous hepatitis B virus infection and heavy smoking in hepatitis C virus-related hepatocellular carcinoma. Am J Gastroenterol 1996;91:1195-203.
39. Chen CJ, Wang LY, Lu SN et al. Elevated aflatoxin exposure and increased risk of hepatocellular carcinoma. Hepatology 1996;24:38-42.
40. Murata M, Takayama K, Choi BC, Pak AW. A nested case-control study on alcohol drinking, tobacco smoking, and cancer. Cancer Detect Prev 1996;20:557-65.
41. Chen ZM, Xu Z, Collins R, Li WX, Peto R. Early health effects of the emerging tobacco epidemic in China. A 16-year prospective study. JAMA 1997;278:1500-4.
42. Lam TH, He Y, Li LS, Li LS, He SF, Liang BQ. Mortality attributable to cigarette smoking in China. JAMA 1997; 278:1505-8.
43. Yu MW, Hsu FC, Sheen IS et al. Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers. Am J Epidemiol 1997;145:1039-47.
44. Liaw KM, Chen CJ. Mortality attributable to cigarette smoking in Taiwan: a 12-year follow-up study. Tob Control 1998;7:141-48.
45. Tanaka K, Sakai H, Hashizume M, Hirohata T. A long-term follow-up study on risk factors for hepatocellular carcinoma among Japanese patients with liver cirrhosis. Jpn J Cancer Res 1998;89:1241-50.
46. Sun Z, Lu P, Gail MH et al. Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1. Hepatology 1999;30:379-83.
47. Yu MW, Chiu YH, Chiang YC et al. Plasma carotenoids, glutathione S-transferase M1 and T1 genetic polymorphisms, and risk of hepatocellular carcinoma: independent and interactive effects. Am J Epidemiol 1999;149:621-29.
48. Mizoue T, Tokui N, Nishisaka K et al. Prospective study on the relation of cigarette smoking with cancer of the liver and stomach in an endemic region. Int J Epidemiol 2000;29:232-37.
49. Mori M, Hara M, Wada I et al. Prospective study of hepatitis B and C viral infections, cigarette smoking, alcohol consumption, and other factors associated with hepatocellular carcinoma risk in Japan. Am J Epidemiol 2000;151:131-39.
50. Evans AA, Chen G, Ross EA, Shen FM, Lin WY, London WT. Eight-year follow-up of the 90,000-person Haimen City cohort: I. hepatocellular carcinoma mortality, risk factors, and gender differences. Cancer Epidemiol Biomarkers Prev 2002;11:369-76.
51. Wang LY, You SL, Lu SN et al. Risk of hepatocellular carcinoma and habits of alcohol drinking, betel quid chewing and cigarette smoking: a cohort of 2416 HBsAg-seropositive and 9421 HBsAg-seronegative male residents in Taiwan. Cancer Causes Control 2003;14:241-50.
52. Jee SH, Ohrr H, Sull JW, Samet JM. Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea. J Natl Cancer Inst 2004;96:1851-56.
53. Ogimoto I, Shibata A, Kurozawa Y et al. Risk of death due to hepatocellular carcinoma among smokers and ex-smokers. Univariate analysis of JACC study data. Kurume Med J 2004;51:71-81.
54. Wen CP, Tsai SP, Chen CJ, Cheng TY. The mortality risks of smokers in Taiwan: Part I: cause-specific mortality. Prev Med 2004;39:528-35.
55. Wang J, Gao YT, Wang XL, Liu EJ, Zhang YL, Yuan JM. Cigarette smoking and cancer mortality: a prospective cohort study in urban males in Shanghai. Zhonghua Liu Xing Bing Xue Za Zhi 2004;25:837-40.
56. Yun YH, Jung KW, Bae JM et al. Cigarette smoking and cancer incidence risk in adult men: National Health Insurance Corporation Study. Cancer Detect Prev 2005;29: 15-24.
57. Fujita Y, Shibata A, Ogimoto I et al. The effect of interaction between hepatitis C virus and cigarette smoking on the risk of hepatocellular carcinoma. Br J Cancer 2006;94: 737-39.
58. Chen CJ, Yang HI, Su J et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006;295:65-73.
59. Ikeda K, Marusawa H, Osaki Y et al. Antibody to hepatitis B core antigen and risk for hepatitis C-related hepatocellular carcinoma: a prospective study. Ann Intern Med 2007; 146:649-56.
60. Ohishi W, Fujiwara S, Cologne JB et al. Risk factors for hepatocellular carcinoma in a Japanese population: a nested case-control study. Cancer Epidemiol Biomarkers Prev 2008;17:846-54.
61. Kew MC, Dibisceglie AM, Paterson AC. Smoking as a risk factor in hepatocellular carcinoma. A case-control study in southern African blacks. Cancer 1985;56:2315-57.
62. Kew MC, Song E, Mohammed A, Hodkinson J. Contraceptive steroids as a risk factor for hepatocellular carcinoma: a case/control study in South African black women. Hepatology 1990;11:298-302.
63. Olubuyide IO, Bamgboye EA. A case-controlled study of the current role of cigarette smoking and alcohol consumption in primary liver cell carcinoma in Nigerians. Afr J Med Med Sci 1990;19:191-94.
64. Mohamed AE, Kew MC, Groeneveld HT. Alcohol consumption as a risk factor for hepatocellular carcinoma in urban southern African blacks. Int J Cancer 1992;51: 537-41.
65. Ryder RW, Whittle HC, Sanneh AB, Ajdukiewicz AB, Tulloch S, Yvonnet B. Persistent hepatitis B virus infection and hepatoma in The Gambia, west Africa. A casecontrol study of 140 adults and their 603 family contacts. Am J Epidemiol 1992;136:1122-31.
66. Stemhagen A, Slade J, Altman R, Bill J. Occupational risk factors and liver cancer. A retrospective case-control study of primary liver cancer in New Jersey. Am J Epidemiol 1983;117:443-54.
67. Austin H, Delzell E, Grufferman S et al. A case-control study of hepatocellular carcinoma and the hepatitis B virus, cigarette smoking, and alcohol consumption. Cancer Res 1986;46:962-66.
68. Yu MC, Henderson BE. Re: a case-control study of hepatocellular carcinoma and the hepatitis B virus, cigarette smoking, and alcohol consumption. Cancer Res 1987;47: 654-55.
69. Yu H, Harris RE, Kabat GC, Wynder EL. Cigarette smoking, alcohol consumption and primary liver cancer: a case-control study in the USA. Int J Cancer 1988;42: 325-28.
70. Hsing AW, Hoover RN, McLaughlin JK et al. Oral contraceptives and primary liver cancer among young women. Cancer Causes Control 1992;3:43-48.
71. Siemiatycki J, Krewski D, Franco E, Kaiserman M. Associations between cigarette smoking and each of 21 types of cancer: a multi-site case-control study. Int J Epidemiol 1995;24:504-14.
72. Hassan MM, Hwang LY, Hatten CJ et al. Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 2002;36: 1206-13.
73. Yuan JM, Govindarajan S, Arakawa K, Yu MC. Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the U.S. Cancer 2004;101:1009-17.
74. Marrero JA, Fontana RJ, Fu S, Conjeevaram HS, Su GL, Lok AS. Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. J Hepatol 2005;42: 218-24.
75. Zhu K, Moriarty C, Caplan LS, Levine RS. Cigarette smoking and primary liver cancer: a population-based casecontrol study in US men. Cancer Causes Control 2007;18: 315-21.
76. Hassan MM, Spitz MR, Thomas MB et al. Effect of different types of smoking and synergism with hepatitis C virus on risk of hepatocellular carcinoma in American men and women: case-control study. Int J Cancer 2008; 123:1883-91.
77. Farker K, Schotte U, Scheele J, Hoffmann A. Impact of Nacetyltransferase polymorphism (NAT2) in hepatocellular carcinoma (HCC)-an investigation in a department of surgical medicine. Exp Toxicol Pathol 2003;54:387-91.
78. Hardell L, Bengtsson NO, Jonsson U, Eriksson S, Larsson LG. Aetiological aspects on primary liver cancer with special regard to alcohol, organic solvents and acute intermittent porphyria-an epidemiological investigation. Br J Cancer 1984;50:389-97.
79. Tzonou A, Trichopoulos D, Kaklamani E, Zavitsanos X, Koumantaki Y, Hsieh CC. Epidemiologic assessment of interactions of hepatitis-C virus with seromarkers of hepatitis-B and -D viruses, cirrhosis and tobacco smoking in hepatocellular carcinoma. Int J Cancer 1991;49:377-80.
80. Filippazzo MG, Aragona E, Cottone M et al. Assessment of some risk factors for hepatocellular carcinoma: a case control study. Stat Med 1985;4:345-51.
81. Trichopoulos D, Day NE, Kaklamani E et al. Hepatitis B virus, tobacco smoking and ethanol consumption in the etiology of hepatocellular carcinoma. Int J Cancer 1987;39: 45-49.
82. La VC, Negri E, Decarli A, D'Avanzo B, Franceschi S. Risk factors for hepatocellular carcinoma in northern Italy. Int J Cancer 1988;42:872-76.
83. Mayans MV, Calvet X, Bruix J et al. Risk factors for hepatocellular carcinoma in Catalonia, Spain. Int J Cancer 1990;46:378-81.
84. Peters M, Wellek S, Dienes HP et al. Epidemiology of hepatocellular carcinoma. Evaluation of viral and other risk factors in a low-endemic area for hepatitis B and C. Z Gastroenterol 1994;32:146-51.
85. Goritsas CP, Athanasiadou A, Arvaniti A, Lampropoulou-Karatza C. The leading role of hepatitis B and C viruses as risk factors for the development of hepatocellular carcinoma. A case control study. J Clin Gastroenterol 1995;20: 220-24.
86. Hadziyannis S, Tabor E, Kaklamani E et al. A case-control study of hepatitis B and C virus infections in the etiology of hepatocellular carcinoma. Int J Cancer 1995;60:627-31.
87. Oral contraceptives and liver cancer. Results of the Multicentre International Liver Tumor Study (MILTS). Contraception 1997;56:275-84.
88. Kuper H, Tzonou A, Kaklamani E et al. Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma. Int J Cancer 2000;85: 498-502.
89. Gelatti U, Covolo L, Talamini R et al. N-Acetyltransferase-2, glutathione S-transferase M1 and T1 genetic polymorphisms, cigarette smoking and hepatocellular carcinoma: a case-control study. Int J Cancer 2005;10;115:301-6.
90. Franceschi S, Montella M, Polesel J et al. Hepatitis viruses, alcohol, and tobacco in the etiology of hepatocellular carcinoma in Italy. Cancer Epidemiol Biomarkers Prev 2006;15:683-89.
91. Lu SN, Lin TM, Chen CJ et al. A case-control study of primary hepatocellular carcinoma in Taiwan. Cancer 1988;62:2051-55.
92. Hiyama T, Tsukuma H, Oshima A, Fujimoto I. [Liver cancer and life style-drinking habits and smoking habits]. Gan No Rinsho 1990;36:249-56.
93. Tsukuma H, Hiyama T, Oshima A et al. A case-control study of hepatocellular carcinoma in Osaka, Japan. Int J Cancer 1990;45:231-36.
94. Chen CJ, Liang KY, Chang AS et al. Effects of hepatitis B virus, alcohol drinking, cigarette smoking and familial tendency on hepatocellular carcinoma. Hepatology 13: 398-406.
95. Choi SY, Kahyo H. Effect of cigarette smoking and alcohol consumption in the etiology of cancers of the digestive tract. Int J Cancer 1991;49:381-86.
96. Lin L, Yang F, Ye Z et al. Case-control study of cigarette smoking and primary hepatoma in an aflatoxin-endemic region of China: a protective effect. Pharmacogenetics 1991;1:79-85.
97. Lin J. [A study on aetiological factors of primary hepatocarcinoma in Tianjin, China]. Zhonghua Liu Xing Bing Xue Za Zhi 1991;12:346-49 (in Chinese).
98. Srivatanakul P, Parkin DM, Khlat M et al. Liver cancer in Thailand. II. A case-control study of hepatocellular carcinoma. Int J Cancer 1991;48:329-32.
99. Yu MW, You SL, Chang AS, Lu SN, Liaw YF, Chen CJ. Association between hepatitis C virus antibodies and hepatocellular carcinoma in Taiwan. Cancer Res 1991; 51:5621-25.
100. Tanaka K, Hirohata T, Takeshita S et al. Hepatitis B virus, cigarette smoking and alcohol consumption in the development of hepatocellular carcinoma: a case-control study in Fukuoka, Japan. Int J Cancer 1992;51:509-14.
101. Fukuda K, Shibata A, Hirohata I, Tanikawa K, Yamaguchi G, Ishii M. A hospital-based case-control study on hepatocellular carcinoma in Fukuoka and Saga Prefectures, northern Kyushu, Japan. Jpn J Cancer Res 1993;84:708-14.
102. Yamaguchi G. Hepatocellular carcinoma and its risk factors-their annual changes and effects on the age at onset. Kurume Med J 1993;40:33-40.
103. Pyong SJ, Tsukuma H, Hiyama T. Case-control study of hepatocellular carcinoma among Koreans living in Osaka, Japan. Jpn J Cancer Res 1994;85:674-79.
104. Tanaka K, Hirohata T, Fukuda K, Shibata A, Tsukuma H, Hiyama T. Risk factors for hepatocellular carcinoma among Japanese women. Cancer Causes Control 1995;6: 91-98.
105. Shin HR, Lee CU, Park HJ et al. Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: a casecontrol study in Pusan, Korea. Int J Epidemiol 1996;25: 933-40.
106. Shibata A, Fukuda K, Nishiyori A, Ogimoto I, Sakata R, Tanikawa K. A case-control study on male hepatocellular carcinoma based on hospital and community controls. J Epidemiol 1998;8:1-5.
107. Mukaiya M, Nishi M, Miyake H, Hirata K. Chronic liver diseases for the risk of hepatocellular carcinoma: a casecontrol study in Japan. Etiologic association of alcohol consumption, cigarette smoking and the development of chronic liver diseases. Hepatogastroenterology 1998;45: 2328-32.
108. Koide T, Ohno T, Huang XE et al. HBV/HCV infection, alcohol, tobacco and genetic polymorphisms for hepatocellular carcinoma in Nagoya, Japan. Asian Pac J Cancer Prev 2000;1:237-43.
109. Takeshita T, Yang X, Inoue Y, Sato S, Morimoto K. Relationship between alcohol drinking, ADH2 and ALDH2 genotypes, and risk for hepatocellular carcinoma in Japanese. Cancer Lett 2000;149:69-76.
110. Yu SZ, Huang XE, Koide T et al. Hepatitis B and C viruses infection, lifestyle and genetic polymorphisms as risk factors for hepatocellular carcinoma in Haimen, China. Jpn J Cancer Res 2002;93:1287-92.
111. Lam TH, Ho SY, Hedley AJ, Mak KH, Peto R. Mortality and smoking in Hong Kong: case-control study of all adult deaths in 1998. BMJ 2001;323:361.
112. Shimada S, Aizawa R, Abe H, Suto S, Miyakawa Y, Aizawa Y. Analysis of risk factors for hepatocellular carcinoma that is negative for hepatitis B surface antigen (HBsAg). Intern Med 2003;42:389-93.
113. Gao JP, Huang YD, Lin JA, Zhu QC, Liang JP. Relationship between genetic polymorphisms of N-acetyltransferase and susceptibility to hepatocellular carcinoma. Zhonghua Gan Zang Bing Za Zhi 2003;11: 20-22.
114. Chen ZM, Liu BQ, Boreham J, Wu YP, Chen JS, Peto R. Smoking and liver cancer in China: case-control comparison of 36,000 liver cancer deaths vs. 17,000 cirrhosis deaths. Int J Cancer 2003;107:106-12.
115. Matsuo M. Association between diabetes mellitus and hepatocellular carcinoma: results of a hospital-and community-based case-control study. Kurume Med J 2003;50: 91-98.
116. Munaka M, Kohshi K, Kawamoto T et al. Genetic polymorphisms of tobacco-and alcohol-related metabolizing enzymes and the risk of hepatocellular carcinoma. J Cancer Res Clin Oncol 2003;129:355-60.
117. Hara M, Tanaka K, Sakamoto T et al. Case-control study on cigarette smoking and the risk of hepatocellular carcinoma among Japanese. Cancer Sci 2008;99:93-97.